Evidence map›Paper›PMID 31949869›Full record

ArticleInternational journal of clinical and experimental pathology2018

Association of GCKR rs780094 polymorphism with circulating lipid levels in type 2 diabetes and hyperuricemia in Uygur Chinese.

Li Wang, Qi Ma, Hua Yao, Li-Juan He, Bin-Bin Fang, Wen Cai, Bei Zhang, Zhi-Qiang Wang, Yin-Xia Su, Guo-Li Du and 5 more

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Li WangKey Laboratory of Xinjiang Metabolic Disease, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Qi MaKey Laboratory of Xinjiang Metabolic Disease, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Hua YaoKey Laboratory of Xinjiang Metabolic Disease, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Li-Juan HeOccupational and Environmental Health, Xinjiang Medical University Xinjiang, China.
Bin-Bin FangClinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Wen CaiDepartment of Nursing, Xinjiang Medical University Xinjiang, China.
Bei ZhangCollege of Fundamental, Xinjiang Medical University Xinjiang, China.
Zhi-Qiang WangOccupational and Environmental Health, Xinjiang Medical University Xinjiang, China.
Yin-Xia SuDepartment of Cadre Healthcare, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Guo-Li DuDepartment of Endocrinology, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Shu-Xia WangDepartment of Cadre Healthcare, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Zhao-Xia ZhangDepartment of Laboratory Medicine,The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Qin-Qin HouClinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Ren CaiClinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Fang-Ping HeDepartment of Liver Disease, The First Affiliated Hospital of Xinjiang Medical University Urumqi, Xinjiang, China.
Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the relationship between a GCKR rs780094 polymorphism and lipid profiles in the Xinjiang Uygur population in China. 980 type 2 diabetes mellitus (T2DM) patients, 1017 hyperuricemia (HUA) and 1185 healthy controls were included in this study. After genotyping of rs780094 by Sequenom Mass ARRAY system, chi-square test and logistic regression analysis were used for association analysis as well as a genotype-phenotype analysis. We found that the serum concentration of TC (P<0.001) was significantly higher and HDL-C (P<0.001) was lower in T2DM than in control participants. Subjects with HUA had a significantly higher TG (P=0.003) and lower HDL-C (P<0.001) than control participants. Additionally, under the recessive model, rs780094 was shown to be associated with the risk of HUA (P=0.015, OR=1.311), particularly in males (P=0.047, OR=1.330). Subsequent interaction analysis between rs780094 and lipid parameters showed that the TG level was positively correlated with HUA in the rs780094- AA+AG carriers (P=0.005). The TC concentrations showed to be associated with T2DM in the rs780094- AA+AG carriers (P<0.001). The association between lipid parameters and gender showed that significantly higher TG levels (P<0.001) and lower HDL-C levels (P<0.001) were observed in female HUA. Higher LDL-C levels were found in male HUA (P=0.015). Moreover, statistically higher TC levels and lower HDL-C levels were found both in male and female T2DM cases (TC: male: P<0.001, female: P=0.014. HDL-C: male: P<0.001, female: P<0.001.).To conclude, our results demonstrated that different genotypes of rs780094 had different effects on blood lipids in HUA and T2DM patients in a Uygur population. Gender was also one of the factors influencing blood lipid levels.

Indexed as

dyslipidemiasGCKRhyperuricemiatype 2 diabetes

Identifiers

PMID31949869
PMCPMC6962982
OpenAlexW3027346661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.